NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 16 June 2011 An observational study has found that mortality was a relative 14% higher in adults (aged 66 years or more) who were initially prescribed tiotropium, compared with […]
Category Archives: Respiratory
NPC Archive Item: New study doesn’t change role of leukotriene receptor antagonists in asthma
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 31 May 2011 A pragmatic randomised study found that a leukotriene receptor antagonist (LTRA) was equivalent to an inhaled corticosteroid (ICS) as first-line preventer therapy, and to a long-acting […]
NPC Archive Item: More data on tiotropium compared with salmeterol in reducing exacerbations in COPD
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Date amended 20 May 2011 Date originally posted 28 April 2011 The POET-COPD randomised controlled trial found that tiotropium reduced the risk of moderate or severe exacerbations, compared with […]
NPC Archive Item: ICS to the rescue for children with mild asthma?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 14th March 2011 A randomised controlled trial (RCT) suggests that inhaled corticosteroids (ICS) plus salbutamol as reliever therapy might be an effective step-down strategy for children (>5years of age) with […]
NPC Archive Item: Inhaled corticosteroids and the risk of diabetes
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 8th February 2011 A Canadian cohort study identified that patients treated for respiratory disease using inhaled corticosteroids (ICS) over a period of 5.5 years were, on average, at a 34% […]
NPC Archive Item: Comparative safety of ICS/LABA combinations in chronic asthma
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 3 June 2010 A Cochrane review found no significant difference in serious adverse events when different combinations of inhaled corticosteroids and long-acting beta2 agonists were compared in people with chronic […]
NPC Archive Item: Tiotropium in asthma – still no good evidence for routine use
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 11 November 2010 A US exploratory study in 210 patients examined the effects of tiotropium in poorly controlled asthma. While hypothesis generating, the study does not provide grounds for clinicians […]
NPC Archive Item: Oral roflumilast▼ launched as add-on treatment for COPD
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 13 October 2010 Roflumilast▼ has been marketed as a once daily add-on treatment to bronchodilator therapy in patients with severe chronic obstructive pulmonary disease (COPD) who have frequent exacerbations. Weight […]
NPC Archive Item: Inhaled corticosteroids more effective than montelukast in reducing asthma exacerbations in children
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 10 September 2010 A meta-analysis has found that inhaled corticosteroids are significantly more effective than montelukast for preventing severe asthma exacerbations requiring systemic corticosteroids in schoolchildren and adolescents with mild-moderate […]
NPC Archive Item: Key licensing studies for indacaterol in COPD published
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 31 August 2010 Indacaterol▼ inhaled once daily improved trough FEV1 at 12 weeks compared to placebo in patients with moderate to severe COPD. Results from the 52-week INVOLVE study […]